Ftse Mib
34.019,55
0,23%
DAX
19.362,52
1,71%
S&P 500
5.969,33
0,68%
NASDAQ
19.244,80
1,38%
Bitcoin
76.358,71
0,95%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Amicus Therapeutics Inc (FOLD) Amicus Therapeutics Inc (FOLD) Notizie

Amicus Therapeutics Inc

FOLD
10,95
-0,29 (-2,58%)
Ultimo aggiornamento: 18:14:30
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/11/202423:03EDGAR2Form 144 - Report of proposed sale of securities
06/11/202422:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202413:01EDGAR2Form 8-K - Current report
06/11/202413:00GLOBEAmicus Therapeutics Announces Third Quarter 2024 Financial..
05/11/202400:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202421:49EDGAR2Form 144 - Report of proposed sale of securities
01/11/202412:00GLOBEAmicus Therapeutics to Present at Upcoming Investor..
28/10/202412:00GLOBEAmicus Therapeutics to Announce Third Quarter 2024 Financial..
17/10/202413:00EDGAR2Form 8-K - Current report
17/10/202413:00GLOBEAmicus Therapeutics Announces Settlement of Galafold®..
04/10/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202413:00GLOBEAmicus Therapeutics Announces Participation at the World..
01/10/202422:35EDGAR2Form 144 - Report of proposed sale of securities
05/9/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202422:19EDGAR2Form 144 - Report of proposed sale of securities
03/9/202413:46GLOBEUPDATE -- Amicus Therapeutics to Present at Upcoming..
03/9/202413:05GLOBEAmicus Therapeutics to Present at Upcoming Investor..
03/9/202413:00GLOBEAmicus Therapeutics Announces Participation at the SSIEM..
30/8/202413:00GLOBEAmicus Therapeutics to Present at Upcoming Investor..
23/8/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202422:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:01EDGAR2Form 8-K - Current report
08/8/202413:00GLOBEAmicus Therapeutics Announces Second Quarter 2024 Financial..
06/8/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202422:25EDGAR2Form 144 - Report of proposed sale of securities
30/7/202413:00GLOBEAmicus Therapeutics to Announce Second Quarter 2024..
09/7/202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202401:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202401:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202401:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202401:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/6/202401:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:38EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/6/202422:06EDGAR2Form 8-K - Current report
05/6/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202413:00GLOBEAmicus Therapeutics to Present at the Goldman Sachs 45th..
09/5/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:00EDGAR2Form 8-K - Current report
09/5/202413:00GLOBEAmicus Therapeutics Announces First Quarter 2024 Financial..
08/5/202413:00GLOBEAmicus Therapeutics to Present at the Bank of America 2024..
01/5/202413:00GLOBEAmicus Therapeutics to Announce First Quarter 2024 Financial..
20/3/202412:00GLOBEAmicus Therapeutics Issues 2024 Environmental, Social, and..
11/3/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:30EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 11,21 Min: 10,725 Max: 11,25
Chiusura: 11,24

La tua Cronologia

NASDAQ
FOLD
Amicus Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network